,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper ...

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...

On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of ...

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...

Mounjaro, the brand name for tirzepatide, is a drug that is used to treat type 2 diabetes by lowering blood sugar levels. It is approved for weight loss in the UK, however Ozempic isn’t licensed ...